bird flu stocks
birdflustocks.com » bird flu stocks  » 
bird flu stocks
Merck/Cidara Therapeutics: Acquisition of Cidara Therapeutics for 221.5 USD/share confirmed
By admin | |
Merck (NYSE: MRK), known as MSD outside of the United
GSK: Canada orders 500.000 H5N1 vaccine doses
By admin | |
PHAC will provide vaccines to provinces and territories based on
Moderna: 590 million USD BARDA funding for bird flu mRNA vaccine development
By admin | |
The U.S. Department of Health and Human Services (HHS) will
Arcturus Therapeutics: Phase 1 H5N1 mRNA vaccine trial initiated
By admin | |
"Interim Phase 1 data expected H2 2025 (...) Arcturus Therapeutics
CSL: United Kingdom government orders 5 million H5 vaccine doses
By admin | |
The UK Government has agreed a contract for more than
Cidara Therapeutics: 105 million USD private placement funding announced
By admin | |
Pursuant to the terms of the securities purchase agreement, Cidara
1 2 3 5